The research strongly helps the appliance of Bio-RFID expertise in non-invasive biomonitoring
Seattle, April 21, 2023– (working wire) –Find out about Labs, Inc. (NYSE American: KNW), an rising developer of non-invasive medical diagnostic expertise, at present introduced the outcomes of a proof-of-principle research titled, “Uncovering the distinctive radio frequency spectral responses of analytes in liquid solutions–implications for non-invasive physiological monitoring.” carried out in collaboration with Mayo Clinic. Know Labs will current the outcomes of the research at American Physiological Affiliation (APS), going down April 20-23 in Lengthy Seaside, California. The research demonstrates the accuracy of Know Labs’ Bio-RFID sensor in measuring numerous analytes within the laboratory, which proves an accuracy price of 100% in these exams. The total research is at present present process a peer-reviewed publication course of.
Know Labs’ expertise platform, Bio-RFID, makes use of electromagnetic power within the type of radio waves to seize non-invasive molecular signatures, which could be transformed into physiologically significant info and insights. Whereas this expertise has been proven to precisely measure many analytes each inside and out of doors the physique, the primary software of this expertise is aimed toward non-invasive glucose monitoring.
“Proof-of-principle research are essential to demonstrating the accuracy of Bio-RFID for non-invasive strategies for medical analysis. This was a vital step in direction of reaching our purpose of delivering the primary FDA-cleared non-invasive glucose monitor to the FDA,” stated Ron Erickson, CEO and Chairman of Know Labs. “To place this in a real-world context: Think about having the ability to constantly and precisely measure numerous elements of your well being on the molecular degree utilizing a pocket-sized (or smaller) sensor as a substitute of a finger prick or a CGM probe.”
The research was carried out on the Mayo Clinic in Rochester, Minnesota in March of 2021, and included 5 experiments designed to reveal the power of a Bio-RFID sensor to non-invasively quantify answer concentrations utilizing a randomized, double-blind trial design, as proxies for biochemical options. Options examined together with water in isopropyl alcohol, sodium chloride in water, and business bleach in water. Information was collected utilizing a Bio-RFID sensor, which generates radio frequency alerts and measures the acquired energy by means of the antenna array. The sensor sweeps throughout the 1500MHz (MHz) – 3000MHz vary at 0.2MHz intervals, and sums values at a frequency of 7501.
stated James “Andy” Anderson, MD, chief medical officer at Know Labs. “What we describe right here is actually groundbreaking. This new software of Bio-RFID expertise to exactly detect and determine particular molecules in a liquid offers highly effective help for non-invasive monitoring of physiologically and medically related analyzes within the human physique.”
For every of the 5 trials, 100% of the options within the check knowledge have been appropriately recognized. Bio-RFID expertise was capable of detect concentrations as little as 2,000 elements per million (ppm) – the equal of precisely measuring the distinction in 0.7 mL of water dropped right into a 12-ounce can of soda – with proof indicating the power to detect far more. . Smaller variations in focus. these within the laboratory The outcomes present proof-of-principle, and strongly help the appliance of the expertise to extra non-invasive, physiological, and medical monitoring.
This proof-of-principle research is a part of a collection of research being carried out by Know Labs through which the corporate is prioritizing exterior validation of its Bio-RFID expertise to non-invasively detect and measure glucose and different analyzes within the physique with excessive ranges of accuracy.
A abstract of the research and the APS Summit poster could be discovered on the web site www.knowlabs.co. The total manuscript might be revealed after peer evaluate.
Mayo Clinic has a monetary curiosity within the expertise described on this information launch. Mayo Clinic will use any income it receives to help its nonprofit mission of affected person care, training, and analysis.
About Know Labs, Inc.
Find out about Labs, Inc. It’s a public firm whose shares are traded on the New York Inventory Trade below the inventory image “KNW”. The corporate’s expertise makes use of spectroscopy to information electromagnetic power by means of a substance or substance to seize a novel molecular signature. The corporate refers to its expertise as Bio-RFID. Bio-RFID expertise could be built-in into quite a lot of wearable, cell or bench wearable type components. This patented, patent-pending expertise allows the identification and monitoring of analyzes beforehand solely attainable with invasive and/or costly and time-consuming laboratory exams. It will likely be the primary software of our Bio-RFID expertise in a product marketed as a non-invasive glucose monitor. It is going to present the person with real-time info on blood glucose ranges. This product would require authorization from the US Meals and Drug Administration earlier than it may be put in the marketplace.
Protected Harbor Assertion
This launch accommodates statements that represent forward-looking statements throughout the which means of the Non-public Securities Litigation Reform Act of 1995 and Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Act of 1934, as amended. These statements seem in numerous locations on this launch and embrace all statements that aren’t statements of historic reality concerning Know Labs, Inc.’s present intent, perception, or outlook. or its administrators or officers in reference to, amongst different issues: (i) financing schemes; (2) traits affecting its monetary place or outcomes of operations. (iii) progress technique and working technique; and (iv) product efficiency. You may determine these statements through the use of the phrases “might,” “will,” “may,” “ought to,” “will,” “plan,” “anticipate,” “anticipate,” “proceed,” “estimate,” “undertaking,” and “undertaking.” Intent”, “potential”, “predict”, “potential”, “potential” and related expressions and variations thereof are meant to determine forward-looking statements. Traders are cautioned that any forward-looking statements aren’t ensures of future efficiency and contain dangers and uncertainties, a lot of that are past the power of Know Labs, Inc. maintains management, and precise outcomes might differ materially from these projected sooner or later.-The statements look like the results of numerous components.These dangers and uncertainties additionally embrace further danger components as mentioned within the Firm’s filings with the U.S. Securities and Trade Fee, together with That is its annual report on Type 10-Ok for the fiscal yr ended September 30, 2022, Types 10-Q and 8-Ok, and in different filings we make with the Securities and Trade Fee occasionally These paperwork can be found within the SEC filings part of the Relationships part. traders on our web site www.knowlabs.co. The Firm cautions readers to not place undue reliance on any of those forward-looking statements, which converse solely as of the date they’re made. The Firm undertakes no obligation to replace any forward-looking assertion to replicate occasions or circumstances after the date of this assertion.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20230421005095/ar/
Contacts
For media inquiries, contact: Know Labs:
the well being
Laura Bastardi
[email protected]
F. (603) 494-6667
Know Labs, Inc. Contact:
Jordyn Hogar
[email protected]
F. (206) 629-6414